about
Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptorsCytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord InjuryInvestigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of painCurrent research on opioid receptor function.Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent ratsDesign and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.Oestrogen modulates cholecystokinin: opioid interactions in the nervous system.Pharmacological strategies in relieving neuropathic pain.Emerging trends in the management of neuropathic pain.Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors.Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids.Structure-activity relationships of bifunctional cyclic disulfide peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla.Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin.Activation of galanin and cholecystokinin receptors in the lumbosacral spinal cord is required for ejaculation in male rats.The brain decade in debate: VIII. Peptide hormones and behavior: cholecystokinin and prolactin.Lack of Analgesic Synergy of the Cholecystokinin Receptor Antagonist Proglumide and Spinal Cord Stimulation for the Treatment of Neuropathic Pain in Rats.
P2860
Q24548810-15DE029D-D2F9-4713-9379-B193B97FD02CQ26740237-3F0FC9D3-DE23-4B5D-AB76-9DEA98D2DA58Q26863769-7AFB9963-B388-44B3-A394-E6C0ECC98C7DQ27693220-FDAA9875-5715-4026-8548-2894B63D9B59Q33640293-64227EBC-F5BD-4F01-BA00-6D87A8D294E0Q35096042-3D6D3B49-F6CB-4CF0-AA04-0B940FBC4B25Q35104450-F2CAA987-68EE-4D3D-B27F-7762F5C9613CQ35784044-6F1E0C76-F71A-4427-B05C-F004BEEC09DCQ36257203-B2B48C6D-8585-41D9-9554-4431286023DEQ36628300-61A03509-F996-4659-B4DB-441834118C82Q36751995-2E467D81-859F-4A89-A3C5-89BAC517C18AQ37012921-C82C7689-6664-42AA-8B8C-C3FB0CD78152Q43518009-F705E0B2-3486-4B45-AEE5-0A1A1AEABC00Q43658586-023ADDB5-6243-4223-9634-8EA6428AEDB8Q44902293-B3E31260-62C0-4F7A-A4BC-3E377433338CQ46644678-E3AC8131-1AFB-4901-800B-BF2BCE28FD6BQ48128534-674A3967-5F27-47C2-A6A6-6E36B0E56719Q48737052-02AC57FC-C07D-4E59-BAA6-EB37481BB0CDQ54091866-D6E23658-AA5C-4E52-8E64-74875E27DC99
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cholecystokinin/opioid interactions.
@ast
Cholecystokinin/opioid interactions.
@en
type
label
Cholecystokinin/opioid interactions.
@ast
Cholecystokinin/opioid interactions.
@en
prefLabel
Cholecystokinin/opioid interactions.
@ast
Cholecystokinin/opioid interactions.
@en
P2093
P1433
P1476
Cholecystokinin/opioid interactions.
@en
P2093
Wiesenfeld-Hallin Z
de Araúja Lucas G
P356
10.1016/S0006-8993(99)01978-2
P407
P577
1999-11-01T00:00:00Z